Refine by
Covid Rapid Articles & Analysis
25 news found
VeriSIM Life has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,908 to conduct research and development (R&D) work on rapid repurposing and translation of approved and investigational drugs for COVID-19 using its patented artificial intelligence (AI) driven biosimulation platform, BIOiSIM. ...
“We need multiple tools in this fight against COVID-19 and remain committed to providing resources to expand access and capacity for testing, which remains a foundational piece of safely reopening the Massachusetts ...
Founded in 2020 in response to the COVID-19 pandemic, Virusight, which is an AI software company, was created to develop an accurate, real-time virus diagnosis solution. ...
Visby Medical™, a leading medical diagnostic company, today announced that it has received an additional $25.5M in federal funding to develop and validate an at-home combination Flu-Covid test from the Biomedical Advanced Research and Development Authority (BARDA).The developmental-stage Flu-COVID PCR Test is a single-use, handheld, all-in-one PCR device ...
This year we aim to launch our first ultra-rapid COVID-19 test products, followed by additional in-vitro diagnostic panels, including inflammation, triage, and hormone tests; as we begin to realize our vision of decentralizing diagnostic ...
The European Investment Bank (EIB) has signed a €20 million loan agreement with Belgian diagnostics company miDiagnostics, to support its research and development activities targeting infectious diseases, and in particular the scale-up of its new rapid COVID-19 PCR Test. The EIB financing is supported by the Infectious Diseases Finance Facility window under ...
Leblond and his team are using the new research infrastructure to create a saliva-based, reagent-free, rapid-screening test for COVID-19. This test uses Raman spectroscopy to analyze saliva in less than two minutes without the need for reagents such as enzymes, which all current chemical COVID-19 tests require. Reagents have become scarce because ...
Anavasi Diagnostics, a medical technology company focused on the development of novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology, today announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative. The funding will accelerate the launch and broad ...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that the Emergency Department at Box Hill Hospital in Melbourne, Australia, has initiated a 300-subject investigator-led trial using Lumos’ FebriDx® POC test to rapidly identify patients presenting with a suspected viral infection consistent with ...
A wide range of perceptions around safety when dialysing in-centre during the COVID-19 pandemic, with two thirds (66%) of in-centre patients concerned about receiving dialysis during the pandemic. 47% of in-centre patients said they were unable to maintain social distancing and 27% of in-centre patients reported concerns about travelling to receive treatment. Many patients who ...
Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant genetic diversity since it first entered the human population. ...
Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its rapid point-of-care COVID-19 antigen test, for use under both the Omega’s VISITECT brand and Global Access Diagnostics (GAD) brand. ...
Regaining our freedom is linked to rapid, reliable testing. The COVID-19 pandemic has underscored the importance of abundant and accurate diagnostics. ...
Newsight Imaging, an Israeli startup developing imaging solutions and chips for spectral and machine vision applications, announced today that the company’s SpectraLIT device, powered by Virusight Diagnostic’s AI software, which enables a ground-breaking 20-second COVID-19 diagnosis, has received the Conformité Européene (CE-European Conformity) ...
(Alveo) announced today that it has been named a winner of the $6M XPRIZE Rapid COVID Testing Competition for its be.well COVID-19 Test. The be.well™ platform provides individuals access to molecular testing and cloud-based analytics for rapid diagnosis and management of infectious diseases. The $6 million XPRIZE ...
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. ...
Baylor Scott & White Research Institute today announces a new research project with Newsight Imaging to evaluate the efficacy of a potential new COVID-19 screening solution. The research project will include the evaluation of Israeli startup Newsight Imaging’s SpectraLIT™ – a portable spectral analysis device powered by machine learning and artificial ...
Yaron Navon, Owner and Managing Director of Lambra ” We are focused on the commercialization of products designed to fight against COVID-19. So far, we offered Rapid tests for anti-bodies and antigens. Our goal is to bring this revolutionary solution to the market, so we are currently immersing ourselves in pilot trial runs with the SpectraLIT™ ...
Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid Covid-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy ...
Empatica's Aura algorithm gives a daily risk-indication of an individual having contracted COVID-19, using physiological data collected by Empatica's medical smartwatch, EmbracePlus. ...